Literature DB >> 7738210

Primary care physicians and the cost of drugs: a study of prescribing practices based on recognition and information sources.

D Walzak1, S Swindells, A Bhardwaj.   

Abstract

Rapidly inflating health care costs limit patient care, and prescription drug costs constitute a major component of this expenditure. This study examines attitudes toward and knowledge of prescription drug costs of primary care physicians. Access to information about drug costs and implications for medical education are also explored. A questionnaire survey was sent to 137 internists, family, and general practitioners, randomly selected from a list provided by the Ohio State Medical Board. The questionnaire elicited information on demographic characteristics of respondents, influence of drug costs on prescribing habits, actual knowledge of prices of the 20 most commonly used drugs, attitudes toward generic drug use, sources of information on costs, and desire for emphasis on drug costs in medical education. Responding physicians indicated consideration of drug costs in therapeutic decisions, but lacked information and often made inaccurate assumptions about costs of drugs prescribed. Most felt they could provide better service and reduce costs if information about drug prices was readily available. Most agreed medical education should address drug costs. Drug cost estimates varied widely; correct responses ranged from 9% to 53%. No statistically significant pattern emerged regarding demographics of respondents or information sources used. Primary care physicians consider drug costs important and realize that cost-effective prescribing may lower health care costs. However, because physician knowledge of drug costs is inadequate and costs are not readily accessible, implications for better physician education and improved abscess are substantial.

Entities:  

Mesh:

Year:  1994        PMID: 7738210     DOI: 10.1002/j.1552-4604.1994.tb04726.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  9 in total

1.  Psychiatrists' knowledge and attitudes about costs of commonly prescribed treatments in psychiatry.

Authors:  D P Bellian; K A King; J Wahl; J H Price
Journal:  J Community Health       Date:  2001-02

2.  Awareness of the side effects of possessed medications in a community setting.

Authors:  Panagiotis N Papanikolaou; John P A Ioannidis
Journal:  Eur J Clin Pharmacol       Date:  2003-03-07       Impact factor: 2.953

3.  Do family physicians know the costs of medical care? Survey in British Columbia.

Authors:  G Michael Allan; Grant D Innes
Journal:  Can Fam Physician       Date:  2004-02       Impact factor: 3.275

4.  Do physicians take cost into account when making prescribing decisions?

Authors:  P Denig; F M Haaijer-Ruskamp
Journal:  Pharmacoeconomics       Date:  1995-10       Impact factor: 4.981

5.  Health professionals: how do they assess new medicines?

Authors:  Rebecca Cheng; Kirsty Cook; Sarah Dowman; Rebecca Lawn; Jemma Leary; Taryn Quinn; Kim Schroder; Nicola Smith; June Tordoff
Journal:  Pharm World Sci       Date:  2005-06

6.  A qualitative comparative investigation of variation in general practitioners' prescribing patterns.

Authors:  Chrys Jaye; Murray Tilyard
Journal:  Br J Gen Pract       Date:  2002-05       Impact factor: 5.386

7.  Improving physicians' knowledge of the costs of common medications and willingness to consider costs when prescribing.

Authors:  Lisa M Korn; Steven Reichert; Todd Simon; Ethan A Halm
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

8.  Does knowledge of medication prices predict physicians' support for cost effective prescribing policies.

Authors:  Jennifer M Polinski; Malcolm Maclure; Blair Marshall; Alan Cassels; Jessica Agnew-Blais; Amanda R Patrick; Sebastian Schneeweiss
Journal:  Can J Clin Pharmacol       Date:  2008-07-19

Review 9.  Physician awareness of drug cost: a systematic review.

Authors:  G Michael Allan; Joel Lexchin; Natasha Wiebe
Journal:  PLoS Med       Date:  2007-09       Impact factor: 11.069

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.